HTR3A and ischemic stroke: This is further complicated by the fact that some 5-HT3 antagonists, including tropisetron, show a bell-shaped dose-response curve [20], leaving open the possibility that lower doses of tropisetron might have complete different effects in permanent ischemic stroke.